330 related articles for article (PubMed ID: 10430307)
41. Hepatectomy of segment 4a and 5 combined with extra-hepatic bile duct resection for T2 and T3 gallbladder carcinoma.
Kohya N; Miyazaki K
J Surg Oncol; 2008 May; 97(6):498-502. PubMed ID: 18314875
[TBL] [Abstract][Full Text] [Related]
42. Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up.
Bahra M; Jacob D; Langrehr JM; Neumann UP; Neuhaus P
J Hepatobiliary Pancreat Surg; 2008; 15(5):501-7. PubMed ID: 18836804
[TBL] [Abstract][Full Text] [Related]
43. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
Lee SG; Song GW; Hwang S; Ha TY; Moon DB; Jung DH; Kim KH; Ahn CS; Kim MH; Lee SK; Sung KB; Ko GY
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):476-89. PubMed ID: 19851704
[TBL] [Abstract][Full Text] [Related]
44. Combined pancreaticoduodenectomy and hepatectomy for patients with locally advanced gallbladder carcinoma: long term results.
Shirai Y; Ohtani T; Tsukada K; Hatakeyama K
Cancer; 1997 Nov; 80(10):1904-9. PubMed ID: 9366291
[TBL] [Abstract][Full Text] [Related]
45. Extrahepatic bile duct cancer. Report of 106 cases.
Cao SH
Chin Med J (Engl); 1992 Aug; 105(8):622-9. PubMed ID: 1458963
[TBL] [Abstract][Full Text] [Related]
46. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
[TBL] [Abstract][Full Text] [Related]
47. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
Meriggi F; Gramigna P; Forni E
Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320
[TBL] [Abstract][Full Text] [Related]
48. [Bile duct carcinoma after abdominal irradiation for urologic malignancies].
Biermann CW; Fröschle G; Kuhlencordt R; Schwarz R; Gonnermann D
Helv Chir Acta; 1994 Dec; 60(6):1131-6. PubMed ID: 7875994
[TBL] [Abstract][Full Text] [Related]
49. Gross appearance of the ampullary tumor predicts lymph node metastasis and outcome.
Kayahara M; Ohta T
Dig Surg; 2010; 27(2):127-31. PubMed ID: 20551657
[TBL] [Abstract][Full Text] [Related]
50. A case of recurrent bile duct cancer initially treated with pancreaticoduodenectomy.
Okamura J; Sakamoto Y
Jpn J Clin Oncol; 2011 Jun; 41(6):832. PubMed ID: 21622763
[No Abstract] [Full Text] [Related]
51. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer.
Yoshida T; Matsumoto T; Sasaki A; Morii Y; Aramaki M; Kitano S
Arch Surg; 2002 Jan; 137(1):69-73. PubMed ID: 11772220
[TBL] [Abstract][Full Text] [Related]
52. An experience of hepatopancreatoduodenectomy in patients with hepatobiliary malignancies.
Nanashima A; Nagasaki T; Sumida Y; Abo T; Tobinaga S; Takeshita H; Nonaka T; Hidaka S; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(86-87):1691-4. PubMed ID: 19102371
[TBL] [Abstract][Full Text] [Related]
53. [A Case of Resected Lymph Node Recurrence of Cancer of the Papilla of Vater].
Harano R; Kusashio K; Yasutomi J; Matsumoto M; Suzuki M; Iida A; Irabu S; Imamura N; Shirokane D; Udagawa I
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1579-81. PubMed ID: 26805102
[TBL] [Abstract][Full Text] [Related]
54. Prognostic factors after pancreatoduodenectomy for distal bile duct cancer.
Qiao QL; Zhang TP; Guo JC; Zhan HX; Zhao JX; Liu YC; Wan YL; Leng XS; Zhao YP
Am Surg; 2011 Nov; 77(11):1445-8. PubMed ID: 22196654
[TBL] [Abstract][Full Text] [Related]
55. Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study.
Petrova E; Rückert F; Zach S; Shen Y; Weitz J; Grützmann R; Wittel UA; Makowiec F; Hopt UT; Bronsert P; Kühn F; Rau BM; Izrailov RE; Khatkov IE; Lapshyn H; Bolm L; Bausch D; Keck T; Wellner UF; Seifert G
Langenbecks Arch Surg; 2017 Aug; 402(5):831-840. PubMed ID: 28612115
[TBL] [Abstract][Full Text] [Related]
56. Cystic duct carcinoma: a proposal for a new "working definition".
Ozden I; Kamiya J; Nagino M; Uesaka K; Oda K; Sano T; Kamiya S; Nimura Y
Langenbecks Arch Surg; 2003 Jan; 387(9-10):337-42. PubMed ID: 12536328
[TBL] [Abstract][Full Text] [Related]
57. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
[TBL] [Abstract][Full Text] [Related]
58. [Malignant tumors of the extrahepatic bile ducts].
Hauser J; Peter MY
Helv Chir Acta; 1970 Aug; 37(4):377-94. PubMed ID: 5518380
[No Abstract] [Full Text] [Related]
59. [Indication and outcome of extended right hemihepatectomy combined with pancreatoduodenectomy for bile duct carcinoma].
Noie T; Seyama Y; Imamura H; Kobayashi A; Miyagawa S; Kawasaki S; Makuuchi M
Nihon Geka Gakkai Zasshi; 2001 Feb; 102(2):215-9. PubMed ID: 11260903
[TBL] [Abstract][Full Text] [Related]
60. Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma.
Yoshida T; Matsumoto T; Sasaki A; Shibata K; Aramaki M; Kitano S
Am J Surg; 2004 Jun; 187(6):736-40. PubMed ID: 15191867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
